BioPlus Co., Ltd. (KOSDAQ:A099430) announces a share repurchase program. Under the program, the company will repurchase up to 5,000 million worth of its shares according to the trust contract with Korea Investment & Securities Co., Ltd. The purpose of the program is to enhance shareholder value and stabilize stock price. The program will expire on June 7, 2022.

As of December 6, 2021, the company had 201,391 shares in treasury within the scope available for dividend and no share under other repurchases.